Beta Bionics (BBNX) Capital Expenditures Growth (1y) (2025 - 2026)
Powered by 
Analysis
Beta Bionics (BBNX) Capital Expenditures Growth (1y) (2025 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -1.00% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -27.50% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -0.20% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 10.38% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 24.20% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 35.70% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 5.88% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -9.99% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -6.52% |
| 10 | Beta Bionics | 873.54 Mn | 693.05 Mn | 18.90 Mn | -41.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -41.60% |
| Mar 31, 2026 | 313.51% |
| Dec 31, 2025 | 239.22% |
| Sep 30, 2025 | -31.74% |
| Jun 30, 2025 | 223.45% |
| Mar 31, 2025 | -17.98% |